Kintara Therapeutics Urges Stockholders to Vote on Merger
Kintara Therapeutics Urges Stockholder Participation in Upcoming Vote
Kintara Therapeutics, Inc. (NASDAQ: KTRA) is reaching out to its stockholders, reminding them of the critical deadline to cast their votes regarding the proposed merger with TuHURA Biosciences. Stockholders are encouraged to ensure that their voices are heard by voting by the specified deadline.
Voting Deadline and Proposal Details
Kintara emphasizes that stockholders must submit their votes by 11:59 p.m. ET to have their input counted. A majority of the voting power from Kintara’s outstanding shares is required for the merger with TuHURA Biosciences to progress.
The Importance of Voting
The company has reported that the voting threshold hasn't yet been met to approve Proposals 3 and 5, which are essential for the completion of the merger. Institutional Shareholder Services and Glass Lewis advocate for a "FOR" vote on these proposals, emphasizing their significance for the company’s future.
Leadership Perspective
Robert E. Hoffman, the Chief Executive Officer of Kintara, has expressed that stockholders' votes are vital for executing the merger successfully. Kintara believes this merger will merge their oncology technologies and assets, aiming to address treatment resistance in cancer care and accelerate their project pipeline with the support of substantial financing.
What the Proposals Entail
Proposal 3 seeks to amend Kintara's Articles of Incorporation by increasing the number of authorized shares, while Proposal 5 discusses the reincorporation of Kintara from its current state to Delaware. These changes are aimed at positioning Kintara for effective future operations and growth.
How to Vote
Kintara provides multiple avenues for stockholders to cast their votes:
- By Phone: North American stockholders can call Alliance Advisors at (866)-619-8907, or international voters can contact them at +1 (551) 210-9859 for assistance.
- By Internet: Votes can be placed through www.proxyvote.com with guidance from your broker or bank.
- Changing Votes: Stockholders can change their votes before the deadline by communicating with Alliance Advisors as mentioned.
All stockholders who owned shares as of the record date should participate in this important decision, even if they don’t currently hold Kintara shares.
About Kintara Therapeutics
Kintara is dedicated to developing innovative cancer therapies that address unmet medical needs. One of their pioneering treatments is REM-001, aimed at addressing cutaneous metastatic breast cancer, demonstrating promising results from previous clinical trials.
The Merger’s Significance
The merger with TuHURA is positioned as a pivotal step for Kintara, which seeks to enhance its capabilities in oncology treatments. TuHURA is recognized for its advanced immuno-oncology products, aiming to improve cancer therapy outcomes. By merging, the two companies can combine their strengths to advance their missions in fighting cancer more effectively.
Frequently Asked Questions
What is the voting deadline for Kintara's stockholders?
The voting deadline is 11:59 p.m. ET, a date crucial for counting votes regarding the merger with TuHURA.
Why is the merger with TuHURA important?
The merger aims to enhance Kintara's capabilities with TuHURA’s advanced technologies, ultimately aiming to improve treatment options for solid tumors.
Who do I contact for voting assistance?
Stockholders can reach out to Alliance Advisors for help with the voting process and any questions they may have.
What proposals require a vote?
Proposals 3 and 5 are critical; they involve increasing the number of authorized shares and reincorporating Kintara from Nevada to Delaware.
How does powering this merger affect Kintara's future?
Successful completion of the merger is expected to strengthen Kintara's financial position and resource capabilities, ultimately aiming to accelerate cancer treatment development.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.